HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$2.73
Day range
$2.70 - $2.90
Year range
$1.05 - $4.24
Market cap
314.32M USD
Avg Volume
1.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.30M | -24.09% |
Operating expense | 17.90M | 54.18% |
Net income | -14.61M | -92.64% |
Net profit margin | -442.98 | -153.78% |
Earnings per share | -0.12 | -9.09% |
EBITDA | -17.04M | -77.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 95.91M | -24.91% |
Total assets | 175.53M | -3.76% |
Total liabilities | 55.43M | 6.11% |
Total equity | 120.10M | — |
Shares outstanding | 108.35M | — |
Price to book | 2.46 | — |
Return on assets | -23.38% | — |
Return on capital | -33.24% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -14.61M | -92.64% |
Cash from operations | -10.93M | -149.69% |
Cash from investing | 13.83M | 394.81% |
Cash from financing | -3.04M | -13,936.36% |
Net change in cash | -146.00K | -100.59% |
Free cash flow | -9.22M | -520.82% |
About
Founded
2012
Website
Employees
63
